Outcome of Patients Treated With ECLS

Launched by NANJING MEDICAL UNIVERSITY · May 26, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the outcomes of patients who are treated with a life-support system called extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO). This treatment helps patients who are experiencing severe heart or lung problems, such as cardiogenic shock, cardiac arrest, heart failure, or serious breathing difficulties. The researchers want to understand how well ECLS works for these patients, looking at both short-term and long-term results after treatment.

The trial is currently recruiting participants of all ages, from infants to older adults, who are receiving ECMO for support with their heart or lung function. If you or a loved one is being considered for ECMO and you agree to participate, you will be part of a study that aims to gather important information about how this treatment helps people in critical condition. The only requirement for joining the trial is that you must be willing to give your consent to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients receiving ECMO for circulatory and/or respiratory support
• Exclusion Criteria:
• • Refusal of consent